Department of Pharmaceutical Technology, Istanbul University, Istanbul, Turkey.
Eur J Pharm Biopharm. 2009 Aug;72(3):487-95. doi: 10.1016/j.ejpb.2009.02.006. Epub 2009 Feb 15.
The aim of this study was to prepare bioadhesive sulfacetamide sodium (SA) microspheres to increase their residence time on the ocular surface and to enhance their treatment efficacy on ocular keratitis. Microspheres were fabricated by spray drying method using mixture of polymers such as pectin, polycarbophil and hydroxypropylmethyl cellulose (HPMC) at different ratios. The particle size and distribution, morphological characteristics, thermal behavior, encapsulation efficiency, mucoadhesion and in vitro drug release studies on formulations have been investigated. After optimisation studies, SA-loaded polycarbophil microsphere formulation with polymer:drug ratio of 2:1 was found to be the most suitable for ocular application and used in in vivo studies. In vivo studies were carried out on New Zealand male rabbit eyes with keratitis caused by Pseudomonas aeruginosa and Staphylococcus aureus. Sterile microsphere suspension in light mineral oil was applied to infected eyes twice a day. Plain SA suspension was used as a positive control. On 3rd and 6th days of the antimicrobial therapy, the eyes were examined in respect to clinical signs of infection (blepharitis, conjunctivitis, iritis, corneal oedema and corneal infiltrates) which are the main symptoms of bacterial keratitis and then cornea samples were counted microbiologically. The rabbit eyes treated with microspheres demonstrated significantly lower clinical scores than those treated with SA alone. A significant decrease in the number of viable bacteria in eyes treated with microspheres was observed in both infection models when compared to those treated with SA alone. In conclusion, in vitro and in vivo studies showed that SA-loaded microspheres were proven to be highly effective in the treatment of ocular keratitis.
本研究旨在制备具有生物黏附性的磺胺醋酰钠(SA)微球,以增加其在眼表面的停留时间,并增强其对眼部角膜炎的治疗效果。采用喷雾干燥法,使用不同比例的果胶、聚卡波非和羟丙甲纤维素(HPMC)等聚合物混合物制备微球。对制剂的粒径及分布、形态特征、热行为、包封效率、黏膜黏附性和体外药物释放进行了研究。经过优化研究,发现聚合物:药物比为 2:1 的载磺胺醋酰钠的聚卡波非微球制剂最适合眼部应用,并用于体内研究。采用金黄色葡萄球菌和铜绿假单胞菌引起角膜炎的新西兰雄性兔进行体内研究。将无菌微球混悬液滴加于感染兔眼,每天 2 次,并用轻质矿物油稀释。采用普通磺胺醋酰钠混悬液作为阳性对照。在抗菌治疗的第 3 天和第 6 天,观察眼睛的感染临床症状(结膜炎、眼睑炎、虹膜炎、角膜水肿和角膜浸润),这是细菌性角膜炎的主要症状,然后对角膜样本进行微生物计数。与单独使用磺胺醋酰钠治疗的兔眼相比,用微球治疗的兔眼的临床评分明显较低。与单独使用磺胺醋酰钠治疗的兔眼相比,在两种感染模型中,用微球治疗的兔眼的活菌数均显著减少。总之,体内外研究表明,载磺胺醋酰钠微球在治疗眼部角膜炎方面具有很高的疗效。